Aquilo Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,456,595
| Closed | -$49.5M | – | 16 |
|
|
2021
Q3 | $49.5M | Buy |
2,456,595
+643,203
| +35% | +$13M | 8.99% | 3 |
|
|
2021
Q2 | $67.7M | Buy |
1,813,392
+108,000
| +6% | +$4.03M | 17.58% | 1 |
|
|
2021
Q1 | $43.6M | Buy |
1,705,392
+350,000
| +26% | +$8.95M | 7.88% | 2 |
|
|
2020
Q4 | $29.9M | Sell |
1,355,392
-19,384
| -1% | -$427K | 6.21% | 4 |
|
|
2020
Q3 | $24.7M | Sell |
1,374,776
-79,910
| -5% | -$1.44M | 2.62% | 3 |
|
|
2020
Q2 | $36.9M | Buy |
1,454,686
+217,307
| +18% | +$5.52M | 7.45% | 1 |
|
|
2020
Q1 | $22.7M | Buy |
1,237,379
+622,943
| +101% | +$11.4M | 8.86% | 2 |
|
|
2019
Q4 | $13.5M | Buy |
+614,436
| New | +$13.5M | 5.08% | 7 |
|